Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Nervous system drugs >  Other nervous system drugs >  BUTALBITAL

BUTALBITAL

Basic information Safety Supplier Related

BUTALBITAL Basic information

Product Name:
BUTALBITAL
Synonyms:
  • 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(2-methylpropyl)-5-(2-propenyl)-
  • BUTALBITAL
  • 5-ALLYL-5-ISOBUTYLBARBITURIC ACID
  • 5-allyl-5-(2’-methyl-n-propyl)barbituricacid
  • 5-Allyl-5-(2'-methyl-n-propyl) barbituric acid
  • 5-Allyl-5-(2-methylpropyl)barbituric acid
  • 5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione
  • 5-allyl-5-isobutyl-barbituricaci
CAS:
77-26-9
MF:
C11H16N2O3
MW:
224.26
EINECS:
201-017-8
Product Categories:
  • API's
  • Amines
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Mol File:
77-26-9.mol
More
Less

BUTALBITAL Chemical Properties

Melting point:
139-140 °C
Boiling point:
365.66°C (rough estimate)
Density 
1.1672 (rough estimate)
refractive index 
1.5000 (estimate)
Flash point:
11 °C
storage temp. 
2-8°C
solubility 
soluble in DMSO, Methanol
form 
Solid
pka
pKa 12.36±0.05(H2O t=38.0 I=0.1) (Uncertain)
color 
White
Water Solubility 
1.702g/L(25 ºC)
BRN 
202119
EPA Substance Registry System
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(2-methylpropyl)-5-(2-propen-1-yl)- (77-26-9)
More
Less

Safety Information

Hazard Codes 
Xn,T,F
Risk Statements 
22-43-39/23/24/25-23/24/25-11
Safety Statements 
36-45-36/37-16
RIDADR 
UN 1230 3/PG 2
WGK Germany 
3
RTECS 
CP8750000
HazardClass 
6.1(b)
PackingGroup 
III
HS Code 
2933530000
Hazardous Substances Data
77-26-9(Hazardous Substances Data)
Toxicity
LD50 oral in bird - wild: 75mg/kg

MSDS

More
Less

BUTALBITAL Usage And Synthesis

Chemical Properties

White, crystalline powder; odorless; slightly bitter taste. Soluble in alcohol, ether, and chloroform; almost insoluble in water.

Originator

Axocet,Savage Labs

Uses

Controlled substance (depressant). Sedative, hypnotic.

Definition

ChEBI: A member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are substituted by an allyl group and an isobutyl group. Frequently combined with other medicines, such as aspirin, paracetamol and codeine, it is used for reatment of pain and headache.

Manufacturing Process

1 mole of sodium is dissolved in 10 to 12 times its weight of absolute alcohol under a reflux condenser. To this are added 1 mole of ethyl malonic acid ester, and then gradually about 1.1 moles of 2-isobutyl bromide. The mixture is gently refluxed for some hours, or until it no longer shows alkaline reaction to moist litmus paper. Most of the alcohol is removed by vacuum distillation, leaving an oily residue. Water is added to this residue to dissolve the sodium bromide; and the oily layer, which is ethyl isopropyl-carbinyl malonic acid ester, is separated and dried. It is purified by fractional distillation in vacuum. When thus purified, ethyl isopropyl-carbinyl malonic acid ester is a colorless or pale yellow liquid, having a boiling point of 103°-105°C at about 4 mm pressure, and a refractive index at 25°C.
3 moles of sodium are dissolved in 10 to 12 times its weight of absolute alcohol under a reflux condenser. To this are added 1.6 moles of urea and 1 mole of ethyl isopropyl-carbinyl malonic acid ester. The mixture is gently refluxed for 2-4 h, after which most of the alcohol is removed by vacuum distillation. The residue is dissolved in water, and a sufficient amount of dilute acid is added to completely precipitate the isopropyl-carbinyl barbituric acid.
The precipitate is filtered off, dried, and recrystallized from dilute alcohol. 1 mole of isopropyl-carbinyl barbituric acid is dissolved in a suitable vessel in a 10%-35% aqueous solution of 1 mole of potassium hydroxide. To this are added somewhat in excess of 1 mole of allyl bromide, and alcohol equal to about 10% of the total volume of the solution. The vessel is agitated for 50- 75 h. At the end of this time, the solution, which may still exhibit two layers, is concentrated to about one-half its volume, to remove the excess allyl bromide and the alcohol. On cooling, an oily layer, which is isopropyl-carbinyl allyl barbituric acid, separates out as a sticky viscous mass. It is dried, washed with petroleum ether, and dissolved in the minimum amount of benzene. Any unreacted isopropyl-carbinyl barbituric acid, which does not dissolve, is filtered off. The addition of petroleum ether to the clear filtrate causes the isopropyl-carbinyl allyl barbituric acid to precipitate as an oily mass. This is separated, washed with petroleum ether, and dried in vacuum.

brand name

Sandoptal (Novartis).

Therapeutic Function

Hypnotic, Sedative

Purification Methods

It can be recrystallised from H2O or dilute EtOH, and sublimes at 100-120o/8-12mm. It is soluble in *C6H6, cyclohexane, tetralin and pet ether at 20o. [Butler et al. J Am Chem Soc 77 1486 1955, Beilstein 24 III/IV 2006.]

BUTALBITALSupplier